MD

Pediatrix Medical Group, Inc.
$26.77
+0.04 (+0.15%)
Mkt Cap 2.20B
Volume 516,906
52W Range 15.7-27.94
Sector Healthcare
Beta 0.65
EPS (TTM) 2.11 USD
P/E Ratio 12.69
Revenue (TTM) 1.95B USD
Rev Growth (5Y) +2.0%
EPS Growth (5Y) -6.3%
AlphaVal · Fair Value
What we estimate one share is worth
$29.10
Fair Value weak signal
8.0% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Stable Earnings Power
30.0 / 100 pillar composite (overridden)
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.91B 2.01B 1.99B 1.97B 1.91B 1.73B 1.78B 3.65B 3.46B 3.18B 2.78B 2.44B
Net Income 165.39M (99.07M) (60.41M) 66.33M 130.96M (796.49M) (1.50B) 268.63M 320.37M 324.91M 336.32M 317.28M
EPS 1.94 -1.19 -0.73 0.80 1.52 -9.31 -17.78 2.95 3.42 3.47 3.59 3.30
Free Cash Flow 252.63M 184.55M 104.00M 137.23M 44.49M 175.83M 338.44M 241.06M 462.07M 404.51M 341.63M 404.58M
FCF / Share 2.96 2.21 1.27 1.65 0.51 2.05 4.02 2.65 5.00 4.38 3.64 4.21
Operating CF 271.09M 206.57M 137.32M 166.94M 76.74M 204.62M 357.71M 289.93M 511.38M 443.78M 368.70M 422.64M
Total Assets 2.25B 2.15B 2.22B 2.35B 2.72B 3.35B 4.15B 5.93B 5.87B 5.34B 4.55B 3.61B
Total Debt 660.30M 662.31M 701.65M 717.08M 1.07B 1.80B 1.79B 1.97B 1.85B 1.71B 1.27B 569.32M
Cash & Equiv 375.24M 229.94M 73.26M 9.82M 387.39M 1.12B 107.87M 36.74M 60.20M 55.70M 51.57M 47.93M
Book Value 865.85M 764.94M 849.06M 891.63M 896.49M 747.49M 1.50B 3.09B 3.07B 2.76B 2.44B 2.27B
Return on Equity 0.19 -0.13 -0.07 0.07 0.15 -1.07 -1.00 0.09 0.10 0.12 0.14 0.14
MD News
Sinopharm Group (OTCMKTS:SHTDY) and Pediatrix Medical Group (NYSE:MD) Financial Survey
Sep 03, 2026 11:48 PM · defenseworld.net
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Sep 03, 2026 08:36 AM · zacks.com
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
Sep 01, 2026 06:46 AM · zacks.com
TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
Aug 27, 2026 04:00 AM · gurufocus.com
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Aug 20, 2026 06:51 AM · zacks.com
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
Aug 13, 2026 08:56 AM · zacks.com
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Aug 12, 2026 06:46 AM · zacks.com
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
Aug 06, 2026 10:00 AM · zacks.com
Pediatrix Medical Group Q2 Earnings Call Highlights
Aug 05, 2026 02:04 AM · marketbeat.com
Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript
Aug 04, 2026 10:10 AM · seekingalpha.com